The European Falsified Medicines Directive
The European Falsified Medicines Directive (EFMD) 2011 is expected affect all UK dispensaries by 2018. Before a product can be dispensed, dispensary staff will have to scan the packaging of all prescription items so that the product’s unique identifier (UI) code can be checked against a data hub using the internet ‘cloud’.
The Dispensing Doctors’ Association supports the purpose of the EFMD, which is to introduce measures to prevent the entry of falsified medicines into the legal supply chain, facilitate product recall and, potentially, stock rotation, but issues such as the funding for the system, and integration of the software into existing and future dispensary IT equipment and software, rural broadband speeds, and the additional workload implications for dispensary staff will all need clarification, the DDA believes.
DDA advice (issued 24 January, 2019)
BMA advice (issued 24 January, 2019)
European Commission. The Falsified Medicines Directive.